Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/26/2022 | Press release | Distributed by Public on 01/26/2022 23:18
Please select the service you want to use:
Smartlinks | Borqs Technologies Inc. | News | Technology | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Corporate and Financial Calendar | Financial Services | Investment Funds | Investment Services | Information Technology | Software | Telecommunications Services | Public Companies | Investment Holding Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact